Platelet Rich Plasma Market, By Type (Pure PRP, Leukocyte rich PRP, Pure PRF, and Leukocyte rich PRF), By Origin (Autologous, Allogenic, and Homologues), By Application (Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI936

Pages :184

Formats :

Excel and PDF

Industry : Biotechnology

Platelet Rich Plasma Market Size and Trends

The global platelet rich plasma market is estimated to be valued at USD 620.5 Mn in 2025 and is expected to reach USD 1,433.7 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032.

Platelet Rich Plasma Market Key Factors

To learn more about this report, Request sample copy

The market is driven by the growing popularity of non-invasive cosmetic procedures and increasing use of platelet rich plasma in therapeutic areas like orthopedic, general surgery, and neurosurgery. The rising adoption of platelet rich plasma therapy over drug therapies due to lesser side effects also supports market expansion. However, high cost of PRP procedures and therapies may hamper the market growth to some extent during the forecast period.

Increasing Number of Cosmetic Surgeries

Increasing number of cosmetic surgeries is expected to propel the growth of the global platelet rich plasma market over the forecast period. For instance, in 2021, according to a survey of the International Society of Aesthetic Plastic Surgery (ISAPS), in 2020, approximately 10,129,528 surgical procedures such as eyelid surgery, ear surgery, and liposuction were performed worldwide and 14,400,347 non- surgical procedures such as hair removal, photo rejuvenation, and botulinum toxin were performed.